Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
825 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00684645 | Non-Interventional Study (NIS) In Patients With Advanced And/Or Metastatic Renal Cell Carcinoma (mRCC) Treated With SUTENT® | completed | — | 186 | PfizerINDUSTRY | 1 | Aug 21, 2012 | clinicaltrials |
| NCT00004861 | Gemcitabine With or Without CI-994 in Treating Patients With Advanced Pancreatic Cancer | completed | Phase 2 | — | PfizerINDUSTRY | 2 | Aug 10, 2012 | clinicaltrials |
| NCT00005093 |
| Gemcitabine With or Without CI-994 in Treating Patients With Advanced Non-small Cell Lung Cancer |
| completed |
| Phase 3 |
| — |
| PfizerINDUSTRY |
| 2 |
| Aug 10, 2012 |
| clinicaltrials |
| NCT00003343 | Chemotherapy in Treating Patients Who Have Metastatic Prostate Cancer | completed | Phase 3 | 525 | PfizerINDUSTRY | 1 | Aug 8, 2012 | clinicaltrials |
| NCT00004199 | Prinomastat and Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Non-small Cell Lung Cancer | completed | Phase 3 | — | PfizerINDUSTRY | 1 | Aug 8, 2012 | clinicaltrials |
| NCT00004200 | Prinomastat Plus Temozolomide Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | completed | Phase 2 | — | PfizerINDUSTRY | 1 | Aug 8, 2012 | clinicaltrials |
| NCT00026273 | Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients Following Surgery for Stage III Colorectal Cancer | completed | Phase 3 | — | PfizerINDUSTRY | 10 | Aug 7, 2012 | clinicaltrials |
| NCT00282048 | Study Of AG-013736 In Patients With Refractory Metastatic Renal Cell Cancer | completed | Phase 2 | 62 | PfizerINDUSTRY | 1 | Jul 31, 2012 | clinicaltrials |
| NCT00393939 | Study Of Sunitinib In Combination With Docetaxel Vs Docetaxel In Patients With Advanced Breast Cancer(SUN 1064) | completed | Phase 3 | 594 | PfizerINDUSTRY | 27 | Jul 19, 2012 | clinicaltrials |
| NCT00471146 | Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer. | completed | Phase 3 | 630 | PfizerINDUSTRY | 24 | Jul 16, 2012 | clinicaltrials |
| NCT01100437 | Safety Study to Assess Opiate Withdrawal Signs and Symptoms in Opioid Dependent Patients | terminated | Phase 4 | 14 | PfizerINDUSTRY | 1 | Jul 13, 2012 | clinicaltrials |
| NCT00246571 | Study Of SU011248 Versus Chemotherapy For Patients With Previously Treated Triple Receptor Negative Breast Cancer | completed | Phase 2 | 217 | PfizerINDUSTRY | 12 | Jul 12, 2012 | clinicaltrials |
| NCT00076011 | Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Renal Cell Carcinoma | completed | Phase 2 | 52 | PfizerINDUSTRY | 3 | Jun 26, 2012 | clinicaltrials |
| NCT00076024 | AG-013736 In Combination With Docetaxel Versus Docetaxel Alone For Patients With Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 174 | PfizerINDUSTRY | 8 | Jun 26, 2012 | clinicaltrials |
| NCT00094055 | Study of the Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Thyroid Cancer | completed | Phase 2 | 60 | PfizerINDUSTRY | 1 | Jun 26, 2012 | clinicaltrials |
| NCT00094094 | Anti-angiogenesis Agent AG-013736 in Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 32 | PfizerINDUSTRY | 2 | Jun 26, 2012 | clinicaltrials |
| NCT00094107 | Anti-Angiogenesis Agent AG-013736 In Patients With Metastatic Melanoma | completed | Phase 2 | 32 | PfizerINDUSTRY | 2 | Jun 26, 2012 | clinicaltrials |
| NCT00435409 | A Study Of Sunitinib In Combination With Capecitabine Compared With Capecitabine In Patients With Breast Cancer | completed | Phase 3 | 442 | PfizerINDUSTRY | 18 | Jun 26, 2012 | clinicaltrials |
| NCT00373113 | A Clinical Trial Comparing Efficacy And Safety Of Sunitinib And Capecitabine | terminated | Phase 3 | 482 | PfizerINDUSTRY | 23 | Jun 25, 2012 | clinicaltrials |
| NCT00424632 | Phase 1 Study Of Aurora Kinase Inhibitor PF-03814735 In Patients With Advanced Solid Tumors | completed | Phase 1 | 57 | PfizerINDUSTRY | 2 | Jun 25, 2012 | clinicaltrials |
| NCT00706355 | A Study of PF-04217903 in Patients With Advanced Cancer | terminated | Phase 1 | 16 | PfizerINDUSTRY | 1 | Jun 25, 2012 | clinicaltrials |
| NCT00071006 | AG-013736 (Axitinib) In Patients With Poor Prognosis Acute Myeloid Leukemia (AML) Or Myelodysplastic Syndrome (MDS) | completed | Phase 2 | 12 | PfizerINDUSTRY | 1 | Jun 8, 2012 | clinicaltrials |
| NCT00447005 | Study Of AG-013736 (Axitinib) In Patients With Advanced Solid Tumors | completed | Phase 1 | 12 | PfizerINDUSTRY | 1 | May 23, 2012 | clinicaltrials |
| NCT00726752 | A Study In Patients With Advanced Solid Tumor | completed | Phase 1 | 6 | PfizerINDUSTRY | 1 | May 23, 2012 | clinicaltrials |
| NCT00090701 | A Phase 2, Open-Label, Multicenter Study of the GARFT Inhibitor in Patients With Metastatic Non-Small Cell Lung Cancer | withdrawn | Phase 2 | 0 | PfizerINDUSTRY | 1 | May 10, 2012 | clinicaltrials |
| NCT01056263 | Retrospective Observational Study To Update 5-Year Survival Of Subjects Who Participated In Axitinib Trial A4061012 | completed | — | 52 | PfizerINDUSTRY | 3 | Apr 20, 2012 | clinicaltrials |
| NCT01033981 | Cost Effectiveness Of Sunitinib In Central America And Caribbean | terminated | — | 4 | PfizerINDUSTRY | 1 | Apr 19, 2012 | clinicaltrials |
| NCT00404495 | Combination of Irinotecan and Temozolomide in Children With Brain Tumors. | completed | Phase 2 | 83 | PfizerINDUSTRY | 8 | Apr 18, 2012 | clinicaltrials |
| NCT00129961 | Study Evaluating the Effect of Sirolimus on Non-Melanoma Skin Cancer in Kidney Transplant Recipients | completed | Phase 4 | 86 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 4 | Apr 11, 2012 | clinicaltrials |
| NCT01305239 | A Survey Of Clinical Practice Of Adjuvant Treatment Of Breast Cancer Using Exemestane (Aromasin®) In Postmenopausal Hr+ Patients(ETAPE) | terminated | — | 398 | PfizerINDUSTRY | 0 | Apr 10, 2012 | clinicaltrials |
| NCT00454649 | Investigational Agent AG-013736 In Combinations With Standard Of Care Treatments For Patient's With Advanced Solid Tumor | completed | Phase 1 | 102 | PfizerINDUSTRY | 3 | Apr 4, 2012 | clinicaltrials |
| NCT00437203 | PF-00477736 Is Being Studied In Advanced Solid Tumors In Combination With Chemotherapy With Gemcitabine | terminated | Phase 1 | 43 | PfizerINDUSTRY | 2 | Apr 3, 2012 | clinicaltrials |
| NCT00557505 | A Study Of PF-03732010 In Patients With Advanced Solid Tumors | completed | Phase 1 | 43 | PfizerINDUSTRY | 3 | Mar 26, 2012 | clinicaltrials |
| NCT01469052 | First In Human, Phase 1 Study of AG013736 In Patients With Solid Tumors | completed | Phase 1 | 36 | PfizerINDUSTRY | 1 | Mar 26, 2012 | clinicaltrials |
| NCT00784888 | Research Of Quality Of Life And Safety Outcomes Of Postmenopausal Breast Cancer Patients Switching From Tamoxifen Therapy To Aromatase Inhibitor Therapy(TAMARA) | completed | — | 344 | PfizerINDUSTRY | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00094029 | A Treatment Protocol for Patients With Gastrointestinal Stromal Tumor (GIST) Who May Derive Benefit From Treatment With SU011248 | approved for marketing | — | — | PfizerINDUSTRY | 34 | Mar 9, 2012 | clinicaltrials |
| NCT00130897 | Treatment Use Study With Sunitinib (SU011248) For Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma | approved for marketing | — | — | PfizerINDUSTRY | 50 | Mar 9, 2012 | clinicaltrials |
| NCT00034957 | Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC) | completed | Phase 2 | — | PfizerINDUSTRY | 1 | Feb 16, 2012 | clinicaltrials |
| NCT00040014 | Open Label, Multicenter, Randomized, Controlled Study of IM or Oral Exemestane (Aromasin) in Postmenopausal Women | terminated | Phase 2 | 100 | PfizerINDUSTRY | 1 | Feb 16, 2012 | clinicaltrials |
| NCT00143390 | Aromasin Vs Arimidex Study As Initial Hormonal Therapy In Postmenopausal Women With Advanced/Recurrent Breast Cancer | completed | Phase 3 | 298 | PfizerINDUSTRY | 1 | Jan 25, 2012 | clinicaltrials |
| NCT00067314 | Study in Women With Metastatic Breast Cancer Whose Cancer Has Gotten Worse After Anthracycline and Taxane Therapy | completed | Phase 2 | 65 | PfizerINDUSTRY | 4 | Jan 18, 2012 | clinicaltrials |
| NCT00492388 | Safety and Efficacy of PMI-150 (Intranasal Ketamine) for the Treatment of Breakthrough Pain in Cancer Patients | terminated | Phase 3 | 2 | Hospira, now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Jan 11, 2012 | clinicaltrials |
| NCT00279448 | Exemestane As Treatment In Adjuvant For Post-Menopausal Patients With Non-Metastatic Breast Cancer(TEAM) | completed | Phase 3 | 9,779 | PfizerINDUSTRY | 1 | Dec 23, 2011 | clinicaltrials |
| NCT01441388 | A Study Of Crizotinib Plus VEGF Inhibitor Combinations In Patients With Advanced Solid Tumors. | withdrawn | Phase 1 | 0 | PfizerINDUSTRY | 0 | Dec 20, 2011 | clinicaltrials |
| NCT00555672 | Study Of Sunitinib In Combination With Cisplatin And 5-Fluorouracil In Patients With Advanced Gastric Cancer | completed | Phase 1 | 34 | PfizerINDUSTRY | 1 | Dec 19, 2011 | clinicaltrials |
| NCT01374139 | Bioequivalence And Food Effect Study Of Bosutinib In Healthy Subjects | completed | Phase 1 | 88 | PfizerINDUSTRY | 1 | Nov 30, 2011 | clinicaltrials |
| NCT00083993 | Study Evaluating CCI-779 and Letrozole in Post-menopausal Women With Breast Cancer | terminated | Phase 3 | 1,236 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 2 | Nov 8, 2011 | clinicaltrials |
| NCT00927043 | Study Evaluating Renal Cell Carcinoma Risk Factors(MICRA) | completed | — | 145 | PfizerINDUSTRY | 1 | Nov 7, 2011 | clinicaltrials |
| NCT00668863 | Study Of Sunitinib With FOLFIRI In Colorectal Cancer | completed | Phase 2 | 71 | PfizerINDUSTRY | 1 | Oct 17, 2011 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials